Skip to main content

Web Content Display Web Content Display

Skip banner

Web Content Display Web Content Display

Head of the PhD study programme:

dr hab. Piotr Rozpądek, Prof. UJ
phone: +48 12 664 6108
e-mail: piotr.rozpadek@uj.edu.pl

PhD Student Administration Office:

mgr Magdalena Pisarczyk
phone: +48 453 672 171
magdalena.pisarczyk@uj.edu.pl

 

Limits of places
[regular recruitment] 2023/24:

1st round (June/July):

MCB: 1
JCET: 2
Solaris: 2

2nd round (September):

MCB: 3
JCET: 0
Solaris: 1

3rd round (October/November):

MCB: 2
JCET: 0
Solaris: 0

Admission:

Admission rules
Admission rules [PL version]
Required documents

Required documents [PL version]
Schedule

Apply via: Online Application System

Past calls:

List of past calls

Web Content Display Web Content Display

>>PhD study programme in Biomedical Sciences<< v. 22/23  [eight-terms]
>>PhD study programme in Biomedical Sciences << v. 22/23 [six-terms]

List of potential PhD advisors [MCB]

PhD Programme in Biomedical Sciences is a programme at the Doctoral School of Exact and Natural Sciences the Jagiellonian University in Krakow with a strong inter-disciplinary, international inter-sectoral research and training dimension.

We will recruit early stage researchers (ESRs) in an open call, targeting the most talented and motivated ESRs in the fields of Biological and Medical Sciences. The recruitment process will adhere to the guidelines set in the code of conduct for the recruitment of researchers and the European charter for researchers, ensuring transparency of the recruitment process based on the merit and skills of applicants. The recruitment process will not discriminate applicants based on their personal features.
Training will be focused on the interest and expertise of researchers working at the Malopolska Centre of Biotechnology (MCB), Jagiellonian Centre for Experimental Therapeutics (JCET) and National Synchrotron Radiation Centre (SOLARIS).
The program covers various areas of biology:

  • synthetic,
  • structural,
  • molecular,
  • cellular,
  • developmental

and utilizes plants, viruses, bacteria, invertebrates and vertebrates.
The program is also linked to interdisciplinary studies in endothelial biomedicine. 

Our Students offered a place in our PhD programme will obtain a full scholarship funded by the Polish government regardless of nationality.
The applicants are free to choose the research topic and supervisors from the focus areas based on their personal interests and qualifications. We encourage our students to get involved in the broad range of scientific activities of MCB, JCET and Solaris research groups. It is also an excellent opportunity to learn to think across disciplines and build up initial collaborations and cross-disciplinary skill sets.
The programme is run in English, either in a six-semester or in an eight-semester system.
During their studies, our students are expected to attend training courses in transferable and general research skills, participate in the students' and outreach activities, present their work regularly and attend seminars.

Web Content Display Web Content Display

Development of beta cell organoids (Supervisor: dr Anna Czarna)

Development of beta cell organoids (Supervisor: dr Anna Czarna)

Project description:

Diabetes is one of the most common diseases of civilization and has become a major health burden worldwide. In the last century, there has been an exponential increase in the incidence of diabetes due to current lifestyle, constant exposure to stress and/or equally strong genetic predisposition. In recent years, much attention has been focused on the role of DYRK1A kinase in β-cell proliferation and its potential as a therapeutic target for the treatment of diabetes. The inhibitors studied by our group are potential regulatory agents that restore pancreatic β-cell mass and the secretory and regulatory functions of this organ. Recent advances in human pluripotent stem cell (hiPSC) technology enable efficient differentiation of hiPSCs into specific cells and provide an excellent platform for disease modeling, drug screening and regenerative approaches. Our group (Kinase Inhibition and Nanotechnology for Diabetes (KIND) research group) differentiates hiPSCs into iPSC-derived β-cells that can produce insulin. The iPSC-derived β-cells are evaluated for drug response to discover compounds suitable for optimal treatment of diabetes.

This project focuses on creating a protein-based matrix to more efficiently prepare hiPSC-derived β-cell organoids. This idea combines tissue engineering with the development of organic surface coating materials to facilitate better growth and efficient differentiation of organoids.

How to apply?

To make the application process fast and easy, please follow the rules. Remember to send your application to Online Application System.

Recommended
Aging-associated, specific pathomechanisms of endothelial dysfunction in sepsis: pathway analysis and experimental therapy (Supervisor: Prof. dr hab. Stefan Chłopicki)

Aging-associated, specific pathomechanisms of endothelial dysfunction in sepsis: pathway analysis and experimental therapy (Supervisor: Prof. dr hab. Stefan Chłopicki)

Aging-associated, specific pathomechanisms of endothelial dysfunction in sepsis: pathway analysis and experimental therapy (Supervisor: Prof. dr hab. Stefan Chłopicki)

Aging-associated, specific pathomechanisms of endothelial dysfunction in sepsis: pathway analysis and experimental therapy (Supervisor: Prof. dr hab. Stefan Chłopicki)

Aging-associated, specific pathomechanisms of endothelial dysfunction in sepsis: pathway analysis and experimental therapy (Supervisor: Prof. dr hab. Stefan Chłopicki)

Aging-associated, specific pathomechanisms of endothelial dysfunction in sepsis: pathway analysis and experimental therapy (Supervisor: Prof. dr hab. Stefan Chłopicki)

Identification and characterization of novel players in HIV-1 RNA nuclear processing and export to dissect post-transcriptional blocks in latency (Project Manager: dr Anna Kula-Pǎcurar)

Identification and characterization of novel players in HIV-1 RNA nuclear processing and export to dissect post-transcriptional blocks in latency (Project Manager: dr Anna Kula-Pǎcurar)